ABSTRACT
At the start of the 1990s, the report of the Financial Action Task Force formed by the Arche Summit estimated a net income of US$85 billion from drug trafficking in the United States and in Europe.1 The scope of these funds, equivalent to half of the world's direct foreign investments or twice the turnover of the arms trade2 in the same period, illustrates the increasing influence of drugs revenue on the international economy and on politics.
